Teekay Corp Ltd (TK) Stock News

Rosen Law Firm has filed securities class action lawsuits against Flotek Industries, FuelCell Energy, and Fluence Energy. The Flotek lawsuit alleges defendants made false statements regarding a Puerto Rico Electric Power Authority contract, claiming there were credible reasons to doubt the consortium's capacity to deliver promised revenues. Investors who purchased securities during specified class periods are encouraged to secure counsel before upcoming lead plaintiff deadlines.

Rosen Law Firm reminds investors who purchased Flotek Industries (FTK) securities between August 3-17, 2026 of the October 26, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges defendants made false statements about a Puerto Rico Electric Power Authority contract, failing to disclose credibility concerns about consortium parties and risks to revenue realization.

Rosen Law Firm is notifying investors of upcoming lead plaintiff deadlines in securities class action lawsuits against Flotek Industries, The Simply Good Foods Company, and Dun & Bradstreet Holdings. The lawsuits allege materially false and misleading statements regarding business operations and financial prospects.

Rosen Law Firm is notifying investors about multiple securities class action lawsuits. The primary case involves Flotek Industries (FTK), where investors who purchased securities between August 3-17, 2026 may be entitled to compensation. The lawsuit alleges that Flotek made materially false statements regarding a Puerto Rico Electric Power Authority contract, failing to disclose credible doubts about the consortium's capacity to deliver on the project. The lead plaintiff deadline is October 26, 2026.

Alpha Teknova (TKNO) has been upgraded to a Zacks Rank #2 (Buy) rating, reflecting upward trends in earnings estimates over the past three months with a 5.2% increase in consensus estimates. The upgrade positions the biopharmaceutical reagent maker in the top 20% of Zacks-covered stocks, suggesting potential near-term stock price appreciation driven by improving business fundamentals.

Holzer & Holzer, LLC announced lead plaintiff deadlines for multiple shareholder class action lawsuits. Taboola.com (TBLA) faces allegations regarding false statements about publisher relationships (deadline: October 20, 2026). GoDaddy Inc. (GDDY) is accused of misstatements about marketing and customer acquisition strategy (deadline: October 20, 2026). Flotek Industries (FTK) faces claims regarding undisclosed risks in its PREPA power generation contract (deadline: October 26, 2026). Investors who purchased shares during the alleged fraud periods and suffered losses are encouraged to seek lead plaintiff status.

Halper Sadeh LLC, an investor rights law firm, is investigating four companies for potential securities law violations and breaches of fiduciary duties related to proposed mergers and acquisitions. The firm is examining whether shareholders are receiving fair consideration and whether insider benefits may be limiting superior competing offers. The investigations cover Beazer Homes' $33.50/share sale, Colony Bankcorp's merger, Atkore's $95.00/share sale, and Bio Green Med Solution's merger.

A class action securities fraud lawsuit has been filed against Flotek Industries (FTK) for allegedly making false statements about a $400 million Puerto Rico power contract that represented 57% of the company's backlog. After Wolfpack Research published a report on August 17, 2026 alleging unauthorized contract manipulation, the contract was subsequently terminated, causing FTK's stock to fall over 32% across three trading days. Investors who purchased shares between August 3-17, 2026 are urged to contact the law firm by October 26, 2026 to participate in the lawsuit.

Rosen Law Firm announces a securities class action lawsuit against Flotek Industries, Inc. (FTK) for allegedly making materially false and misleading statements regarding a Puerto Rico Electric Power Authority (PREPA) power generation project contract. The lawsuit claims defendants failed to disclose credible doubts about the consortium parties' experience and financial capacity, creating risk that contract revenue would not be realized. The lead plaintiff deadline is October 26, 2026.

Schall, Brown & Schwartz LLP announced a class action securities fraud lawsuit against Flotek Industries (FTK) for making false and misleading statements regarding its power generation project with Puerto Rico's Electric Power Authority (PREPA). The lawsuit alleges the company failed to disclose credible doubts about PREPA's financial capacity and organizational ability to complete the work. The class period spans August 3-17, 2026, with a deadline of October 26, 2026 for investors to participate.

Law Offices of Howard G. Smith has announced securities fraud class action lawsuits against four publicly-traded companies: Flotek Industries, Aevex Corp, Fractyl Health, and GoDaddy Inc. The lawsuits allege materially false and misleading statements regarding business operations and prospects. Investors have until October 2026 to file lead plaintiff motions.

Rosen Law Firm reminds investors of Flotek Industries who purchased securities between August 3-17, 2026 of the October 26, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Flotek made materially false and misleading statements regarding a Puerto Rico Electric Power Authority power generation project contract, failing to disclose credible doubts about the consortium parties' experience and financial capacity.

Law firm Lowey Dannenberg is investigating Flotek Industries (NYSE: FTK) for potential federal securities violations following the cancellation of a major $400 million power generation agreement with Puerto Rico's Electric Power Authority (PREPA). The agreement represented 57% of Flotek's backlog. After Wolfpack Research published a critical report on August 17, 2026, PREPA terminated the contract, causing Flotek's stock to plummet approximately 20% ($7.17 per share). The investigation focuses on whether Flotek and its executives concealed risks and provided accurate information to investors.

Wolf Haldenstein has filed a class action lawsuit against Flotek Industries for allegedly making false and misleading statements about a $400 million PREPA power generation contract. The lawsuit covers investors who purchased shares between August 3-14, 2026. After Wolfpack Research published a report on August 17, 2026 alleging the contract was canceled, Flotek's stock price dropped approximately 20%, declining $7.17 per share to close at $28.66.

Pomerantz Law Firm has filed a class action lawsuit against Flotek Industries (NYSE: FTK) alleging securities fraud. The lawsuit stems from Flotek's announcement of a $400M contract with Puerto Rico's Electric Power Authority (PREPA) on August 3, 2026, which was subsequently canceled on August 18, 2026. Wolfpack Research reported that the contract was terminated due to unauthorized use of another contractor's signature and federal regulatory concerns. Flotek's stock fell 20.01% on August 17 and an additional 5.72% on August 18. Investors have until October 26, 2026, to request Lead Plaintiff status.

A class action securities fraud lawsuit has been filed against Flotek Industries (FTK) for allegedly making false statements about a $400 million Puerto Rico power contract that represented 57% of the company's backlog. After Wolfpack Research published a report on August 17, 2026 alleging unauthorized contract manipulation, the contract was subsequently terminated, causing FTK's stock to fall over 32% across three trading days. Investors who purchased shares between August 3-17, 2026 are urged to contact the law firm by October 26, 2026 to participate in the lawsuit.

Rosen Law Firm has filed a securities class action lawsuit against Flotek Industries (FTK) on behalf of investors who purchased securities between August 3-17, 2026. The lawsuit alleges that defendants made materially false and misleading statements regarding a Puerto Rico Electric Power Authority (PREPA) power generation project contract, failing to disclose credible doubts about the consortium parties' experience and financial capacity, which created risk that projected revenues would not materialize.

Montauk Renewables (MNTK) has received a Zacks Rank #1 (Strong Buy) rating due to significantly improved earnings estimates. The company's consensus earnings estimate for the current quarter increased 25% year-over-year to $0.05 per share, while full-year estimates surged 1,100% to $0.12 per share. The stock has already gained 24.6% over the past four weeks, reflecting investor confidence in its earnings growth prospects.

In a value investing comparison, Allstate (ALL) emerges as the better opportunity compared to Tokio Marine Holdings (TKOMY). Allstate holds a Zacks Rank of #1 (Strong Buy) with superior valuation metrics including a forward P/E of 7.46 versus TKOMY's 15.37, a PEG ratio of 0.60 versus 1.47, and a P/B ratio of 2.07 versus 2.66. Allstate received a Value grade of A while TKOMY scored a C.

Timken (TKR) reported strong Q2 2026 earnings of $1.83 per share, beating estimates by 12.3%, with sales up 7.5% year-over-year. The company raised its full-year 2026 guidance for both earnings and revenue. However, despite the positive earnings beat, shares have underperformed the S&P 500 by 8.5% over the past month, with analyst estimates trending downward since the report.

Cytokinetics announced additional positive results from ACACIA-HCM and MAPLE-HCM studies showing aficamten improved cardiac structure and diastolic function in non-obstructive HCM patients, and outperformed metoprolol in obstructive HCM. The company plans to file for nHCM approval in Q4 2026, potentially expanding the drug's addressable market. Myqorzo received FDA approval in December 2025 for obstructive HCM treatment.

The State Street SPDR NYSE Technology ETF (XNTK) is a passively managed fund tracking 35 U.S. technology companies with a low 0.35% expense ratio and $1.85 billion in assets. The ETF has gained 26.7% year-to-date and 45.7% over the past year, earning a Zacks ETF Rank of 1 (Strong Buy). However, it carries higher volatility with a beta of 1.45 and concentrated exposure with only 37 holdings.

Robbins LLP announced a securities class action lawsuit against Flotek Industries for allegedly misleading investors about a $400 million Puerto Rico power generation contract. The contract was announced on August 3, 2026, but canceled by August 17, 2026, causing Flotek's stock to drop 20.01%. Investors who purchased FTK securities during this period may be eligible to participate, with a lead plaintiff deadline of October 26, 2026.

Rosen Law Firm has filed securities class action lawsuits against Flotek Industries (FTK) for allegedly making false statements about a Puerto Rico Electric Power Authority contract, and against Intuit Inc. (INTU) for undisclosed issues. Investors with losses are encouraged to join the lawsuits before upcoming deadlines (October 26, 2026 for FTK and September 8, 2026 for INTU).

Novartis announced positive Phase III REMODEL-1/-2 trial results for remibrutinib, a BTK inhibitor for relapsing multiple sclerosis. The drug showed superiority over teriflunomide in reducing annualized relapse rates and MRI lesions, with clinically meaningful disability progression delays and a favorable safety profile. Novartis plans to submit for regulatory approval globally.

Law firm Lowey Dannenberg is investigating Flotek Industries (NYSE: FTK) for potential federal securities violations following the cancellation of a major $400 million PREPA power generation agreement. The contract represented 57% of Flotek's revenue backlog. After Wolfpack Research published a critical report on August 17, 2026, PREPA terminated the agreement, causing Flotek's stock to plunge $7.17 per share (20%) to $28.66. The investigation focuses on whether Flotek concealed risks and provided accurate information to investors.

Grabar Law Office announced investigations into shareholder claims against four companies: Aardvark Therapeutics for allegedly misleading statements about drug safety leading to 56% stock decline; Flotek Industries for misrepresentations regarding a terminated Puerto Rico power project; GoDaddy for failing to disclose impact of promotional pricing on bookings; and Hub Group for material financial statement misstatements. Long-term shareholders may pursue corporate reforms and compensation.

TKMS sees increased demand from Middle East following Iran war  Reuters

SRx Health Solutions (NYSE: SRXH) has acquired a 4.99% stake in Smartkem, Inc. (NASDAQ: SMTK), a leader in advanced materials, through a shelf take down. The company also purchased convertible preferred securities in a non-brokered private placement. This acquisition comes as SRx Health Solutions is in the process of merging with EMJ Crypto Technologies (EMJX).

TKO Group Holdings Inc. (NYSE: TKO ) is absorbing a $30 million loss to host an ultra-exclusive UFC match on the White House South Lawn curated by President Donald Trump , but Wall Street experts tell Benzinga the political spectacle is a calculated gamble that will pay off for the company’s bottom line. Ultimate Status Symbol For Washington? A hand-curated ticket from Trump to the custom-built UFC octagon on the White House South Lawn is currently the ultimate status symbol in Washington. But for TKO Group, the parent company of the UFC and WWE, the spectacle comes with a hefty price tag: an expected $30 million net loss for the upcoming second-quarter UFC Freedom 250 event. While retail investors might balk at the eight-figure expense, Wall Street analysts are looking past the political flash to the underlying fundamentals. ‘Discretionary, Unique’ Global Stage For Ian Moore , VP and Research Analyst for U.S. Entertainment at Bernstein , the high-stakes gamble is exactly what TKO needs to execute its long-term strategy. Moore maintains an “Outperform” rating on the stock with a $240 price target, noting that the underlying monetization engine is working so well that TKO can afford to take a hit for the sake of mainstream visibility. “I think the Freedom 250 event is well understood by the street at this point – $60M loss with $30M recouped primarily via sponsorship,” Moore exclusively told Benzinga . “Engagement metrics I follow, including US ratings for fights YTD, appear to be soaring already, so my view is that this is more of a discretionary, unique & very high-profile opportunity to promote the UFC on a global stage.” Moore emphasized that the bulk of TKO’s earnings before interest, taxes, depreciation, and amortization (EBITDA) is locked ... Full story available on Benzinga.com